Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|January 9, 2003
Identification of new drug sensitivity genes using genetic suppressor elements: protein arginine N-methyltransferase mediates cell sensitivity to DNA-damaging agentsLaurent Gros, Charlotte Delaporte, Stéphane Frey, et al.
Oncoimmunology|November 11, 2017
PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibodyLaetitia They, Henri-Alexandre Michaud, Ondine Becquart, et al.
Oncoimmunology|January 4, 2018
IL-21 promotes the development of a CD73-positive Vγ9Vδ2 T cell regulatory populationClément Barjon, Henri-Alexandre Michaud, Angeline Fages, et al.
Scientific Reports|January 27, 2021
Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cellsMaëva Chauvin, Véronique Garambois, Pierre-Emmanuel Colombo, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 1, 2025
FSTL3 is a biomarker of poor prognosis and associated with immunotherapy resistance in ovarian cancerMaeva Chauvin, Estelle Tromelin, Julien Roche-Prellezo, et al.
Cancer Immunology Research|November 19, 2014
Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activityJeremy Bastid, Anne Regairaz, Nathalie Bonnefoy, et al.
Plos One|October 1, 2009
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KITPatrice Dubreuil, Sébastien Letard, Marco Ciufolini, et al.
Journal of Neuroinflammation|July 13, 2016
Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosisEmiliano Trias, Sofía Ibarburu, Romina Barreto-Núñez, et al.
International Journal of Oncology|May 20, 2021
Anti-Müllerian hormone concentration regulates activin receptor-like kinase-2/3 expression levels with opposing effects on ovarian cancer cell survivalMaëva Chauvin, Véronique Garambois, Sylvie Choblet, et al.
Nature Communications|November 12, 2017
Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacologyKahina Hammam, Magali Saez-Ayala, Etienne Rebuffet, et al.
Pageof 5